Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 45 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

31%

14 trials in Phase 3/4

Results Transparency

14%

1 of 7 completed trials have results

Key Signals

18 recruiting1 with results

Enrollment Performance

Analytics

N/A

13(38.2%)

Phase 3

12(35.3%)

Phase 2

4(11.8%)

Phase 4

2(5.9%)

Early Phase 1

2(5.9%)

Phase 1

1(2.9%)

34Total

N/A(13)

Phase 3(12)

Phase 2(4)

Phase 4(2)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (45)

Showing 20 of 45 trials

NCT05160987Not ApplicableRecruiting

Effect of Remimazolam With Protocolized Sedation on Critical Ill, Mechanical Ventilated Patients Compared With Midazolam

Role: collaborator

NCT07327216Phase 3Recruiting

Sapylin Versus Dexamethasone Inhalation for CCRT-Induced Oral Mucositis in Nasopharyngeal Carcinoma

Role: lead

NCT05198609Phase 3Active Not Recruiting

Camrelizumab, Apatinib Plus HAIC Versus Camrelizumab and Apatinib for HCC With Portal Vein Invasion: a Randomized Trial

Role: collaborator

NCT06462313Not ApplicableCompleted

Dobutamine for Management of Surgical Patients With Septic Shock

Role: collaborator

NCT07201337Phase 3Recruiting

Reduced-dose vs Standard-dose Irradiation for Low-risk Clinical Target Volume in Nasopharyngeal Carcinoma.

Role: collaborator

NCT03649503Recruiting

The National Registry Study For the Real-world Patients With Parkinsonian Disorders in China

Role: collaborator

NCT07136519Phase 2Not Yet Recruiting

Toripalimab, Induction Chemotherapy, Radiation Therapy With Omega-3 for Locally Advanced Nasopharyngeal Carcinoma

Role: lead

NCT06214767Recruiting

Study on Treatment Decision-Making and Prognostic Follow-Up for Untreated Cerebral Cavernous Malformations

Role: collaborator

NCT07072000Phase 3Not Yet Recruiting

Shrinking the Anterior Border of CTV2 for Nasopharyngeal Carcinoma to Reduce the Radiation of Nasal Cavity

Role: collaborator

NCT06940960Not ApplicableRecruiting

JY231(JY231) Injection for the Treatment of Relapsed/Refractory B Cell Lymphoma/ Leukemia

Role: lead

NCT05482230Not ApplicableCompleted

Application of Tracheal Intubation in Lateral Position in Thoracic Surgery

Role: collaborator

NCT05289908Phase 1Completed

Intrathecal Pemetrexed for Leptomeningeal Metastasis

Role: collaborator

NCT06904183Phase 2Recruiting

Lenvatinib, Sintilimab, and DEB-TACE With/Without HAIC for HCC >7 cm With PVTT

Role: collaborator

NCT06926959Recruiting

Tricuspid RegurgitAtion rIsk modeL Study (TRAIL Study)

Role: collaborator

NCT06712888Phase 3Recruiting

Toripalimab Vs. Placebo Wtih GP Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma

Role: collaborator

NCT06810791Phase 3Recruiting

HVA vs IA/DA or VA in the Treatment of ND HR-AML

Role: collaborator

NCT02966483Not ApplicableRecruiting

Transanal Versus Laparoscopic Total Mesorectal Excision for Rectal Cancer

Role: collaborator

NCT06763666Phase 4Not Yet Recruiting

CLAG+VEN vs CLAG in the Treatment of Relapsed/Refractory AML

Role: collaborator

NCT06716762Completed

Open vs. Laparoscopic Surgery for Pediatric Choledochal Cyst

Role: collaborator

NCT06647264Enrolling By Invitation

A Multicenter Prospective Observational Study of Computer-aided Risk Perception and Prognosis Prediction in the Whole Process of Laparoscopic Hepatobiliary and Pancreatic Surgery

Role: collaborator